Clinical Trials

NCT07024784 | RECRUITING | PHASE2

377 participants

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-07-30
Completion:: 2028-01-31

Conditions

Gynecologic Cancers
Platinum-Sensitive Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer (PSOC)

Interventions

DRUG

No Results Yet

NCT07023705 | COMPLETED

53 participants

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-29
Start Date:: 2024-01-01
Completion:: 2024-12-31

Conditions

Pulmonary Embolism (Diagnosis)
Diagnosis

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT07023289 | RECRUITING | PHASE2

140 participants

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-09-02
Completion:: 2029-11-30

Conditions

Colorectal Cancer

Interventions

DRUG

No Results Yet

NCT07011732 | RECRUITING | PHASE3

352 participants

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-07-10
Completion:: 2028-11-24

Conditions

Alzheimer Disease

Interventions

DRUG

No Results Yet

NCT07005128 | RECRUITING | PHASE3

330 participants

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-08-18
Completion:: 2029-01-04

Conditions

Small-cell Lung Cancer
Extensive Stage Small-cell Lung Cancer

Interventions

DRUG

No Results Yet

NCT07000825 | ENROLLING_BY_INVITATION | NA

80 participants

EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-10-06
Completion:: 2027-12-01

Conditions

Metabolic Syndrome
Diabetes
Oxidative Stress
Dyslipidemia
Inflamation

Interventions

DIETARY_SUPPLEMENT

No Results Yet

NCT06998303 | RECRUITING | NA

20 participants

Imaging Core Aim 2, and Udall Project 2 Aim 2

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-01
Completion:: 2027-07-31

Conditions

Parkinson Disease

Interventions

OTHER

No Results Yet

NCT06997497 | RECRUITING | PHASE3

477 participants

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-07-16
Completion:: 2029-03-28

Conditions

Colon Adenocarcinoma
Rectal Adenocarcinoma

Interventions

DRUG
BIOLOGICAL

No Results Yet

NCT06989320 | RECRUITING | NA

80 participants

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-27
Completion:: 2030-12-31

Conditions

Healthy Volunteer
Kidney Stones
Kidney Calculi
Urolithiasis
Urolithiasis, Calcium Oxalate
Nephrolithiasis
Nephrolithiasis, Calcium Oxalate
Oxalate Urolithiasis
Healthy

Interventions

DIETARY_SUPPLEMENT

No Results Yet

NCT06987539 | RECRUITING | PHASE2

15 participants

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2026-08-31
Completion:: 2030-03-13

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG

No Results Yet

NCT06985498 | SUSPENDED | PHASE2

40 participants

Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-06-01
Completion:: 2029-06-01

Conditions

Acute Lymphobkastic Leukemia

Interventions

COMBINATION_PRODUCT

No Results Yet

NCT06973720 | ACTIVE_NOT_RECRUITING | PHASE2

268 participants

A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-07
Completion:: 2025-12-16

Conditions

Obesity
Overweight or Obesity

Interventions

DRUG

No Results Yet

NCT06964412 | ACTIVE_NOT_RECRUITING | NA

36 participants

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2026-02-03
Completion:: 2027-05-30

Conditions

Prostate Cancer

Interventions

OTHER

No Results Yet

NCT06963827 | RECRUITING | PHASE3

347 participants

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-07-15
Completion:: 2028-09-07

Conditions

Kidney Disease

Interventions

DRUG

No Results Yet

NCT06955195 | RECRUITING | NA

18000 participants

Youth-for-Youth Mental Wellness Care and Action

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-08-21
Completion:: 2027-08-31

Conditions

Mental Well-being
Adolescent Health
Mental Health Literacy
School Difficulties Associated With Mental Health Problems
Mental Health Help-Seeking

Interventions

BEHAVIORAL
OTHER

No Results Yet

NCT06952530 | ACTIVE_NOT_RECRUITING | PHASE3

487 participants

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-30
Completion:: 2027-09-30

Conditions

Hypertension

Interventions

DRUG

No Results Yet

NCT06948435 | ACTIVE_NOT_RECRUITING | PHASE3

487 participants

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-30
Completion:: 2027-09-30

Conditions

Hypertension
Overweight or Obesity

Interventions

DRUG

No Results Yet

NCT06948422 | ACTIVE_NOT_RECRUITING | PHASE3

974 participants

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-30
Completion:: 2027-09-30

Conditions

Hypertension

Interventions

DRUG

No Results Yet

NCT06944821 | COMPLETED | NA

90 participants

Effect of in Situ Simulation on Quality of Work Life and Multiprofessional Team Effectiveness in the Intensive Care Unit

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-19
Completion:: 2026-04-17

Conditions

Quality of Work Life
Burn-out
Simulation

Interventions

PROCEDURE
OTHER

No Results Yet

NCT06944353 | ENROLLING_BY_INVITATION | NA

4704 participants

Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-12-04
Completion:: 2027-01-31

Conditions

Non-Alcoholic Fatty Liver Disease
Steatosis of Liver
Metabolic Dysfunction-Associated Steatotic Liver Disease

Interventions

BEHAVIORAL

No Results Yet

NCT06941792 | ACTIVE_NOT_RECRUITING | PHASE4

1590 participants

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-06-17
Completion:: 2027-04-30

Conditions

Coronary Heart Disease

Interventions

DRUG
COMBINATION_PRODUCT

No Results Yet

NCT06940310 | COMPLETED | NA

61 participants

Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-09
Completion:: 2025-12-19

Conditions

Breast Cancer

Interventions

BEHAVIORAL

No Results Yet

NCT06934252 | RECRUITING | PHASE1

115 participants

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-02
Completion:: 2027-09-02

Conditions

Moderate-to-severe Atopic Dermatitis

Interventions

DRUG

No Results Yet

NCT06932341 | RECRUITING | NA

8000 participants

Evaluation of the Impact of EHR-Alerts on Clinical Decision Support Pathway Use in Bronchiolitis, and the Impact of Pathway Use on the Prescription of High Flow Nasal Cannula and Other Elements of High Value Care.

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-05
Completion:: 2026-06-14

Conditions

Bronchiolitis

Interventions

OTHER

No Results Yet

NCT06932263 | RECRUITING | PHASE2

540 participants

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-03-26
Completion:: 2027-06-24

Conditions

Asthma

Interventions

DRUG

No Results Yet

NCT06930690 | RECRUITING | PHASE1/PHASE2

70 participants

Dexamethasone for Ureteral STent Symptoms (DUSTS)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2026-06-30
Completion:: 2026-12-31

Conditions

Ureteral Stent-Related Symptom

Interventions

DRUG

No Results Yet

NCT06930508 | RECRUITING | NA

83 participants

Bringing Medicines for HIV Prevention to a Family Planning Clinic

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2026-05-28
Completion:: 2026-07-31

Conditions

HIV
PrEP

Interventions

BEHAVIORAL

No Results Yet

NCT06926868 | RECRUITING | PHASE2/PHASE3

500 participants

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-09-11
Completion:: 2028-03-13

Conditions

Breast Neoplasms

Interventions

DRUG

No Results Yet

NCT06926660 | ACTIVE_NOT_RECRUITING | PHASE2

492 participants

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-07-18
Completion:: 2026-08-20

Conditions

Chronic Kidney Disease

Interventions

DRUG

No Results Yet

NCT06925737 | RECRUITING | PHASE3

1440 participants

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-13
Completion:: 2028-06-26

Conditions

Prostate Cancer
Prostatic Neoplasms

Interventions

DRUG

No Results Yet

NCT06924970 | ACTIVE_NOT_RECRUITING | PHASE2

59 participants

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-01
Completion:: 2026-05-31

Conditions

Sickle Cell Disease

Interventions

DRUG

No Results Yet

NCT06919471 | RECRUITING | NA

90 participants

Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-08
Completion:: 2028-05-01

Conditions

Dietary Monitoring

Interventions

OTHER

No Results Yet

NCT06915402 | COMPLETED | NA

26 participants

Efficacy and Safety of "LMW - CL - HA - FACE/BODY" for the Augmentation of the Cheeks

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-06-24
Completion:: 2026-04-13

Conditions

Esthetics

Interventions

DEVICE

No Results Yet

NCT06910813 | RECRUITING | PHASE1/PHASE2

30 participants

DFT383 in Pediatric Participants With Nephropathic Cystinosis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-06-02
Completion:: 2031-03-14

Conditions

Nephropathic Cystinosis

Interventions

GENETIC

No Results Yet

NCT06903416 | RECRUITING | PHASE2/PHASE3

10 participants

Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-05-07
Completion:: 2030-03-30

Conditions

Spinal Cord Injury Cervical

Interventions

OTHER

No Results Yet

NCT06897202 | COMPLETED | PHASE2

133 participants

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-03-14
Completion:: 2025-12-29

Conditions

Obesity in Diabetes
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG

No Results Yet

NCT06893276 | NOT_YET_RECRUITING | NA

60 participants

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2026-07-01
Completion:: 2026-11-27

Conditions

Pancreatic Cancer

Interventions

BEHAVIORAL

No Results Yet

NCT06890884 | RECRUITING | PHASE2

594 participants

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-04-11
Completion:: 2027-12-13

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

BIOLOGICAL
DRUG

No Results Yet

NCT06890338 | RECRUITING | PHASE2

140 participants

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-11-21
Completion:: 2030-02-28

Conditions

Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Neoadjuvant

Interventions

DRUG

No Results Yet

NCT06890208 | COMPLETED

176 participants

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-29
Start Date:: 2025-06-11
Completion:: 2025-09-12

Conditions

Coronary Disease
Myocardial Infarction
Heart Failure
Arrhythmias, Cardiac
Peripheral Artery Disease
Stroke
Ischemic Attack, Transient
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Pulmonary Disease, Chronic Obstructive
Asthma
Renal Insufficiency
Depressive Disorder
Anxiety Disorders
Schizophrenia
Peripheral Nervous System Diseases

Interventions

OTHER

No Results Yet